Form 8-K - Current report:
SEC Accession No. 0001641172-25-019893
Filing Date
2025-07-16
Accepted
2025-07-16 16:15:56
Documents
12
Period of Report
2025-07-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 35300
  Complete submission text file 0001641172-25-019893.txt   198442

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE indp-20250714.xsd EX-101.SCH 3020
3 XBRL LABEL FILE indp-20250714_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE indp-20250714_pre.xml EX-101.PRE 22362
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3579
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 251127631
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)